Hubei Huaqiang High-Tech Co., Ltd.

SHSE:688151 Stock Report

Market Cap: CN¥5.8b

Hubei Huaqiang High-Tech Past Earnings Performance

Past criteria checks 1/6

Hubei Huaqiang High-Tech's earnings have been declining at an average annual rate of -57%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 29% per year. Hubei Huaqiang High-Tech's return on equity is 0.1%, and it has net margins of 1%.

Key information

-57.0%

Earnings growth rate

-61.3%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate-29.0%
Return on equity0.1%
Net Margin1.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Hubei Huaqiang High-Tech Co., Ltd. (SHSE:688151) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Oct 01
Hubei Huaqiang High-Tech Co., Ltd. (SHSE:688151) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Revenue & Expenses Breakdown

How Hubei Huaqiang High-Tech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688151 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24552612859
30 Jun 24533613458
31 Mar 24502513253
31 Dec 23573813052
30 Sep 23499-213952
30 Jun 23522113554
31 Mar 235501013063
31 Dec 225866812766
30 Sep 2271311116171
30 Jun 221,00222517273
31 Mar 221,21529617268
31 Dec 211,27532017459
30 Sep 211,33233912139
31 Dec 2083517614240
31 Dec 191,64813012944
31 Dec 187431039429

Quality Earnings: 688151 has a large one-off gain of CN¥84.2M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 688151 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688151's earnings have declined by 57% per year over the past 5 years.

Accelerating Growth: 688151 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 688151 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.8%).


Return on Equity

High ROE: 688151's Return on Equity (0.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 02:03
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Huaqiang High-Tech Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution